1. Zhao B, Wang Z, Ling Y, Zhou S, Wu S, Dong S, Xie Y, Li L, Sun Y, Wang J, Ji H, Yan Y, Li Y, Guo J, Tian T, Xiao W (2013) Phase III clinical trial of Diterpene Ginkgolides Meglumine Injection for syndrome of stagnant phlegm blocking collaterals in convalescence of atherosclerotic thrombotic cerebral infarction. Chin Tradit Herbal Drugs 44(24):3525–30
2. Zhao B, Wang Z, Ling Y, Zhou S, Wu S, Dong S, Xie Y, Li L, Sun Y, Wang J, Ji H, Yan Y, Li Y, Guo J, Tian T, Xiao W (2013) Phase III clinical trial of Diterpene Ginkgolides Meglumine Injection for syndrome of stagnant phlegm blocking collaterals in convalescence of atherosclerotic thrombotic cerebral infarction. Chin Tradit Herbal Drugs 44(24):3525–30
3. Chen C, Zhou J, Chen J, Chang X, Zhang L, Wang Z (2014) Protective effects of ginkgo terpene lactones meglumine injection on focal cerebral ischemia reperfusion injury in rats. Chin J Exp Tradit Med Form 20(17):133–6
4. Mahadevan S, Park Y (2008) Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci 73(1):R14–19
5. Chan PC, Xia Q, Fu PP (2007) Ginkgo biloba leave extract: biological, medicinal, and toxicological effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25(3):211–44